Login
Toggle navigation
Videos
Categories
Trending
Mike Crawley, CEO of Northland Power, joins BNN Bloomberg to discuss recent company updates, developments, and upcoming projects.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mike Crawley. President/CEO, Northland Power Inc ;
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Managing Minds and Climate Action: Insights from Ricardo Mussa, CEO of Raízen | Ricardo Mussa, CEO , Raízen SA.
00:10:00
BioLargo's CEO Dennis Calvert Highlights Major Growth Catalysts for the Company | Dennis Calvert , CEO, BioLargo Inc.
00:10:00
Carnarvon Energy says core focus is on Dorado FID | Adrian Cook, CEO, Carnarvon Energy LtdCVN:ASX
00:10:00
A Conversation with Christian Sinding on Investment Strategies and Market Dynamics | Christian Sinding, CEO, EQT Partners.
00:10:00
Strategies for Navigating Economic Uncertainty: A Practical Perspective | Tim Buckley, CEO , Vanguard .
00:10:00
Roberto Funari, on Leadership, Career Growth, and Building High-Performing Teams | Roberto Funari, CEO , Alpargatas SA.
00:10:00
Our vision was to create a better hedge fund option that was truly clientâcentric|Cesar Bello, Partner,Corbin Capital Partners, L.P.
00:10:00
"Building A Legacy of Wealth with Generation Capital Founder" highlights how the founder of Generation Capital shares insights on wealth-building strategies across generations.
00:10:00
Insights and updates from the leader of PetVivo Holdings.|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:10:00
Planning Your Unique Retirement Journey: An Agile Overview
00:10:00
ESG Reflections & Future Outlook | Susan H. Mac Cormac - Partner of morrison foerster
00:10:00
Fusion: Reviving Liberty and Tradition in American Political Thought|Samuel Goldman,Professor,George Washington University